{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:30:00Z","timestamp":1790519400305,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.009","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:24:16Z","timestamp":1535873056000},"page":"3460-3462","source":"Crossref","is-referenced-by-count":6,"title":["Oral Dipyridamole-Associated Circulatory Collapse"],"prefix":"10.1016","volume":"27","author":[{"given":"Pasi","family":"Jolma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki","family":"Ollikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Uurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000327035","article-title":"The Japanise aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial","volume":"31","author":"Uchiyama","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0003","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0026-895X(25)10421-5","article-title":"Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole","volume":"30","author":"Jarvis","year":"1986","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0004","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.CIR.0000101927.70100.41","article-title":"Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: relevance to therapeutic preconditioning in humans","volume":"108","author":"Gamboa","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/0024-3205(86)90401-7","article-title":"Cardiovascular effects of adenosine infusion in man their modulation by dipyridamole","volume":"39","author":"Biaggioni","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02329923","article-title":"Role of endogenous adenosine in vasovagal syncope","volume":"11","author":"Sinkovec","year":"2001","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0007","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/01.STR.0000179044.37760.9d","article-title":"Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole","volume":"36","author":"Gamboa","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nuclcard.2005.03.003","article-title":"Cardiogenic shock after dipyridamole administration for myocardial perfusion imaging","volume":"30","author":"Jafary","year":"2005","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0009","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1345\/aph.1P734","article-title":"Dipyridamole-associated shock and pulmonary edema","volume":"45","author":"Dioverti","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0167-5273(93)90108-S","article-title":"Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers","volume":"42","author":"Roach","year":"1993","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0011","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-137-1-200207020-w1","article-title":"Adenosine and aggrenox: a hazardous combination","volume":"137","author":"Littman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00003072-199702000-00005","article-title":"Asystole during dipyridamole infusion in patients without coronary artery disease or beta-blocker therapy","volume":"22","author":"Frossard","year":"1997","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0013","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.83.5.1499","article-title":"Cardiac eletrophysiology of adenosine. Basic and clinical concepts","volume":"83","author":"Lerman","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.08.009_bib0014","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718304518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T15:48:26Z","timestamp":1751816906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718304518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1052305718304518"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.08.009","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}